Results 81 to 90 of about 11,421 (234)
Psychedelics in the treatment of unipolar and bipolar depression
This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression. Since the 1990s, psychedelics experience a renaissance in biomedical research.
Oliver G. Bosch +2 more
doaj +1 more source
Abstract Background and aims Australia recently down‐scheduled and authorised psychedelic‐assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness.
Sarah J. Catchlove +3 more
wiley +1 more source
The combination of exercise and psychedelics for the treatment of major depressive disorder
Upwards of 50% of people do not respond to the primary treatment modalities for major depressive disorder (MDD), which has led to increased attention and use of alternative methods, including exercise and psychedelics.
Nicholas Fabiano +7 more
doaj +1 more source
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve +6 more
wiley +1 more source
Media hype regarding psychedelic treatments for depression and PTSD from 2017 to 2024
Enthusiastic media coverage of psychedelics as a treatment for mental health disorders is perceived as hyped compared to coverage of established treatments.
Audrey Evers +4 more
doaj +1 more source
The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance
Recent scientific findings spanning the past two decades have prompted a reevaluation of psychedelics, including psilocybin, LSD, and MDMA, as potent tools for mental health treatment. While these substances were historically associated with countercultural movements, concerns and excitement arise as they become commercialized.
Minsu Yoo, Sofia Sakopoulos
openaire +1 more source
Abstract Aims ‘Mad honey’ is produced when bees collect nectar from Rhododendron species containing grayanotoxins, naturally occurring diterpenoid toxins that can produce dose‐dependent intoxication. It has long been embedded in Nepalese medicinal and ritual practices but has recently become part of global psychedelic discourse. This study examined how
Sharon R. Sznitman, Surendra Tiwari
wiley +1 more source
Psychedelic medicine: The biology underlying the persisting psychedelic effects
Psychedelic substances have regained interest as therapeutic agents in the treatment of stress-related disorders. The effects seem to be of persisting nature even after a single dose. Also in lower than 'regular' recreational doses, so-called micro-doses, without the typical effects on consciousness, users report beneficial effects on cognitive ...
openaire +3 more sources
Abstract Aims To characterize changes in preferred e‐cigarette (EC) flavor, nicotine concentration, wattage and air valve openness over 12 weeks among adults who smoke and are attempting to switch to ECs, and examine whether these changes are associated with cigarettes smoked per day (CPD).
Yoo Jin Cho +11 more
wiley +1 more source
Unlocking Psychedelics’ Medical Potential
“I am he as you are he as you are me and we are all together,” John Lennon sang in 1967. The lyrics—which Lennon wrote on an acid trip—express the mystical dissolution of self that users of psychedelic drugs often experience.
Jacobs, Peter +2 more
core +1 more source

